
    
      The number of patients admitted at the hospital, their comorbidity (Charlson index), the
      number of previous treatments, the length of admission, the need or not of the Intensive Care
      Unit (ICU) and their final status (survivors or non survivors) would be studied.

      If patients that previously received the influenza vaccine or treated with ACEI or ARB showed
      a better evolution, it would be proposed to extend vaccination and the inclusion of ACE
      inhibidors and ARB in the treatment of infection.
    
  